Laparoscopic ventral hernia repair: postoperative antibiotics decrease incidence of seroma-related cellulitis

C Edwards1, J Angstadt, O Whipple

  • 1Department of Surgery, Mercer University School of Medicine, Memorial Health University Medical Center, Savannah, Georgia, USA.

The American Surgeon
|December 24, 2005
PubMed

Insights

Postoperative antibiotics significantly reduce cellulitis after laparoscopic ventral hernia repair. This study found that 7-day antibiotic courses prevent seroma-related infections, improving patient outcomes.

Area of Science:

  • Surgical Complications
  • Infectious Disease Prevention
  • Hernia Surgery

Background:

  • Seroma formation is a frequent complication following laparoscopic ventral herniorrhaphy.
  • Limited recent data exists on seroma-related cellulitis incidence and prevention strategies.

Purpose of the Study:

  • To assess the efficacy of postoperative prophylactic antibiotics in preventing seroma-related cellulitis after laparoscopic ventral herniorrhaphy.
  • To evaluate the impact of antibiotic regimens on seroma formation and subsequent infection.

Main Methods:

  • Retrospective case review of 65 laparoscopic ventral herniorraphies performed between February 2002 and January 2004.
  • Comparison of two antibiotic groups: preoperative antibiotics only versus preoperative plus 7-day postoperative antibiotics.
  • Analysis of seroma formation, cellulitis incidence, and mesh infection rates.

Main Results:

  • Seroma formation rates were similar between groups (30% vs. 33%).
  • Seroma-related cellulitis occurred in 100% of the preoperative-only group versus 40% in the postoperative antibiotic group.
  • Two mesh infections requiring removal occurred in the preoperative-only group; none in the postoperative group.

Conclusions:

  • Laparoscopic ventral hernia repair is safe and effective, with a comparable seroma rate.
  • Postoperative prophylactic antibiotics significantly reduce the incidence of seroma-related cellulitis.
  • A 7-day course of postoperative antibiotics is a safe and effective strategy to limit seroma-related cellulitis and prevent mesh infection.